Lilly plans another study for Alzheimer's drug
Eli Lilly's experimental Alzheimer's drug has flashed potential to help with mild cases of the disease, but patients and doctors will have to wait a ...

Pfizer to pay $55 million in drug misbranding case
The Justice Department says Pfizer Inc. will pay $55 million to resolve allegations that its subsidiary Wyeth LLC promoted the drug Protonix for uses ...
Jan. date to rule on BP $4.5B plea deal over spill
A federal judge will decide next month whether to accept a plea deal that calls for BP PLC to pay a record $4.5 billion in penalties for its role in ...
New Alzheimer's drug studies offer patients hope
For Alzheimer's patients and their families, desperate for an effective treatment for the epidemic disease, there's hope from new studies starting up ...
Drugmaker Ranbaxy halts generic Lipitor production
Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles ...
Ranbaxy recalls generic Lipitor doses
Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass ...

Defense lawyers say BP rig workers are scapegoats
While BP has resolved a sweeping criminal probe of its role in the massive 2010 oil spill in the Gulf of Mexico, two company employees charged in the ...

BP agrees to pay $4.5B; 3 employees charged
A day of reckoning arrived for BP on Thursday as the oil giant agreed to plead guilty to a raft of charges in the deadly Gulf of Mexico spill and pay ...

BP near settlement with US over Gulf spill
British oil company BP said Thursday it is in advanced talks with U.S. agencies about settling criminal and other claims from the Gulf of Mexico well ...
Pfizer says FDA approves arthritis drug Xeljanz
Pfizer says the Food and Drug Administration approved its rheumatoid arthritis pill Xeljanz (ZEL'jans), seen as potential big seller for the world's ...

Study: Vitamins don't lower heart risks in men
Multivitamins might help lower the risk for cancer in healthy older men but do not affect their chances of developing heart disease, new research ...

US stocks rise on strong economic data
It's only been a day, but November on Wall Street is already looking a lot better than October. Strong economic data and corporate news converged ...

Pfizer 3Q profit falls 14 pct on generic Lipitor
Drug giant Pfizer Inc. said Thursday that its third-quarter profit fell 14 percent as sales plunged, mainly due to increased U.S. generic competition ...

Sandy unlikely to damage US economy, analysts say
Airlines have canceled thousands of flights, stranding travelers around the globe. Insurers are bracing for possible damages of $5 billion.

Hurricane Sandy shuts stock trading for 2 days
Remember when President Grover Cleveland ran for a second consecutive term, Jack the Ripper spread terror in London and Kaiser Wilhelm II became ...
Storm leads companies to postpone earnings reports
A number of major U.S. companies postponed quarterly earnings reports scheduled for Monday and Tuesday, as Hurricane Sandy barreled into the East ...
3 companies reschedule 3Q reports due to storm
Pfizer Inc., NRG Energy and Entergy are rescheduling the release of their third quarter 2012 earnings reports because of the major storm bearing down ...
Clarification: Earns-Johnson & Johnson story
In a story Oct. 16 on Johnson & Johnson's third-quarter results, The Associated Press reported that J&J would take a $340 million charge for ending ...

Multivitamins may lower cancer risk in men
America's favorite dietary supplements, multivitamins, modestly lowered the risk for cancer in healthy male doctors who took them for more than a ...

Stocks higher after retail sales improve
Stocks rose on Monday after a strong gain in retail spending suggested that consumers could be getting more confident about the economy. Bank stocks ...

Alzheimer drug shows some promise in mild disease
Combined results from two studies of an experimental Alzheimer's drug suggest it might modestly slow mental decline, especially in patients with mild ...

Benefits seen in hormone use early in menopause
A new study may reassure some women considering short-term use of hormones to relieve hot flashes and other menopause symptoms. Starting low-dose ...